IPO Annual Meeting 2010
The Pharmaceutical Issues Committee and the Discovery & Litigation Committees have organized CLE breakout sessions on Monday, September 13, 2010 at IPOs Annual Meeting in Atlanta, GA.
Paul Hastings partner David Conca is a featured speaker during the A New Patent Dance: The Biologics Price Competition and Innovation Act discussion from 1:45 pm to 3:15 pm.
This sessionwill provide an overview of the recently enacted Biologics Price Competition and Innovation Act, which provides a new regulatory pathway for FDA approval of biosimilars. Various requirements, exclusivities and incentives for reference product sponsors and biosimilar applicants, mechanisms for instituting patent litigation, comparisons between this new legislation and the existing Hatch-Waxman scheme, status of implementation by the FDA, and issues that are likely to arise under the new law will be discussed.
Paul Hastings partner Preston Ratliff is a featured speaker during the Best Practices in Multi-Defendant Litigation discussion from 1:45 pm to 3:15 pm.
Litigation strategy and discovery issues arising in multi-defendant settings where joint defense teams have to work together efficiently and effectively.
For more information and to register, visitwww.ipo.org/am2010.